Kim C M, Dion S B, Onorato J J, Benovic J L
Department of Pharmacology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107.
Receptor. 1993 Spring;3(1):39-55.
The beta-adrenergic receptor kinases, beta ARK1 and beta ARK2, are two recently cloned members of the G protein-coupled receptor kinase family. To further characterize these kinases, bovine beta ARK1 and beta ARK2 have been overexpressed in Sf9 insect cells using the baculovirus expression system. High yields (5-7 mg/L cells) of purified kinase preparations were obtained by sequential chromatography of infected Sf9 cell supernatant fractions on S-Sepharose and Heparin-Sepharose. The expressed kinases were fully active as evidenced by their ability to specifically phosphorylate the agonist-occupied beta 2-adrenergic receptor (beta 2AR) and light-activated rhodopsin. Similar initial rates and maximal stoichiometries of beta 2AR phosphorylation were observed for both beta ARK1 and beta ARK2. Moreover, G protein beta gamma subunits enhanced the initial rates of both beta ARK1 and beta ARK2 mediated beta 2AR phosphorylation by approximately tenfold. In the presence of beta gamma subunits the maximal stoichiometry of beta 2AR phosphorylation was increased from approximately 4 mol phosphate/mol receptor to approximately 10 mol/mol. Detailed kinetic analysis of rhodopsin phosphorylation suggests that both kinases follow a sequential mechanistic pathway and have similar Kms for rhodopsin (approximately 14 microM) and MgATP (60-90 microM). Peptide phosphorylation studies demonstrate that both kinases prefer acidic amino acids amino terminal to a serine. Heparin was found to be the most potent inhibitor for both kinases with IC50s of 1.4 and 1.1 microM for beta ARK1 and beta ARK2, respectively. These studies demonstrate that beta ARK1 and beta ARK2 share very similar kinetic properties and suggest that they may have a similar substrate specificity in vivo.
β-肾上腺素能受体激酶βARK1和βARK2是G蛋白偶联受体激酶家族中最近克隆出的两个成员。为了进一步表征这些激酶,利用杆状病毒表达系统在Sf9昆虫细胞中过表达了牛βARK1和βARK2。通过将感染的Sf9细胞上清液组分依次在S-Sepharose和肝素-Sepharose上进行层析,获得了高产率(5-7mg/L细胞)的纯化激酶制剂。所表达的激酶具有完全活性,这可通过它们特异性磷酸化激动剂占据的β2-肾上腺素能受体(β2AR)和光激活视紫红质的能力得以证明。βARK1和βARK2对β2AR磷酸化的初始速率和最大化学计量比相似。此外,G蛋白βγ亚基将βARK1和βARK2介导的β2AR磷酸化的初始速率提高了约10倍。在存在βγ亚基的情况下,β2AR磷酸化的最大化学计量比从约4摩尔磷酸/摩尔受体增加到约10摩尔/摩尔。对视紫红质磷酸化的详细动力学分析表明,这两种激酶均遵循顺序机制途径,并且对视紫红质(约14μM)和MgATP(60-90μM)具有相似的Km值。肽磷酸化研究表明,这两种激酶均优先磷酸化丝氨酸氨基末端的酸性氨基酸。发现肝素是这两种激酶最有效的抑制剂,βARK1和βARK2的IC50分别为1.4和1.1μM。这些研究表明,βARK1和βARK2具有非常相似的动力学特性,并表明它们在体内可能具有相似的底物特异性。